Illumina (ILMN) Tops Q1 EPS by 24c

Illumina (NASDAQ: ILMN) reported Q1 EPS of $1.60, $0.24 better than the analyst estimate of $1.36. Revenue for the quarter came in at $846 million versus the consensus estimate of $835.53 million.

“This was a strong start to the year, with $846 million in revenue and more than $1 billion in orders for the first time in Illumina’s history,” said Francis deSouza, President and CEO. “Our growth is driven by a broad range of sequencing applications, with 14% sequencing consumable growth in the first quarter, including more than 20% growth in clinical sequencing consumables.”

For earnings history and earnings-related data on Illumina (ILMN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c